
Axinn announced on Wednesday, January 1, that Bradley Justus, a member in the firm’s Antitrust group, has been promoted to partner. Dan Oakes, a member in the firm’s Antitrust group, and Jarod Taylor, a member in the firm’s Litigation group, have also been promoted to Counsel.
“Bradley, Dan, and Jarod are well-deserving of their promotions,” said Matthew Becker, Managing Partner of the firm. “Each of these extraordinarily talented lawyers are valued by our clients for their impressive legal skills and unique and innovative approaches. We congratulate each of them on their accomplishments so far and look forward to their continued contributions to Axinn and the legal community.”
Bradley Justus is based in the firm’s Washington, DC, office and focuses his practice on antitrust law, including mergers, antitrust litigation, government investigations and counseling. He has significant experience in large global M&A transactions, appearing before the U.S. Department of Justice and Federal Trade Commission, in addition to representing clients in merger reviews by European, Brazilian, Canadian, and Mexican competition regulators.
Also based in the firm’s Washington, DC, office, Dan Oakes focuses his practice on criminal antitrust investigation, antitrust litigation, merger analysis, and antitrust counseling. He has represented domestic and foreign corporate clients in international cartel investigations before the DOJ, the Canadian Competition Bureau, and European Commission. Dan also has significant experience leading merger, civil non-merger and other internal investigations.
Jarod Taylor, based in the firm’s Hartford office, has experience with litigation in federal courts across the country, as well as with arbitration and internal and governmental investigations. He has litigated cases involving contract disputes, business torts, patent infringement, and Fair, Reasonable And Non-Discriminatory (“FRAND”) licensing obligations.
Full Content: Axinn
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas